SanBio Co Ltd
OTC:SNBIF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SanBio Co Ltd
OTC:SNBIF
|
JP |
|
A
|
APTIV PLC
F:D7A
|
CH |
|
P
|
Public Storage
F:PUP
|
US |
|
E
|
Enterprise Metals Ltd
ASX:ENT
|
AU |
|
Grupo Televisa SAB
NYSE:TV
|
MX |
|
E
|
Edel SE & Co KgaA
DUS:EDL
|
DE |
|
Old Second Bancorp Inc
F:OSB
|
US |
|
Ekinops SA
PAR:EKI
|
FR |
|
Blue Bird Corp
NASDAQ:BLBD
|
US |
|
Oneview Healthcare PLC
OTC:ONVVF
|
IE |
|
Aeroflot-Rossiyskiye Avialinii PAO
MOEX:AFLT
|
RU |
|
NatWest Group PLC
F:RYSD
|
UK |
|
TMX Group Ltd
TSX:X
|
CA |
|
S
|
SSR Mining Inc
XMUN:ZSV
|
US |
|
I
|
IAMGOLD Corp
F:IAL
|
CA |
|
WH Group Ltd
F:0WH
|
HK |
|
S
|
Surteco Group SE
F:SUR
|
DE |
|
Liberty Metals Ltd
ASX:LIB
|
AU |
|
S
|
Svas Biosana SpA
MIL:SVS
|
IT |
|
S
|
StepChange Holdings Ltd
ASX:STH
|
AU |
|
V
|
Volatus Aerospace Inc
DUS:ABB
|
CA |
Intrinsic Value
Is SNBIF undervalued or overvalued?
See the intrinsic value estimate for 
SanBio Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What SanBio Does
SanBio Co Ltd is a Japanese biotechnology company focused on regenerative medicine. It develops cell-based therapies designed to repair damaged tissue, especially for serious conditions affecting the brain and central nervous system. Its main products are experimental and approved cell treatments built around its own cell-processing and manufacturing know-how.
- Headquarters
- Japan JP
- Employees
- 33
- IPO date
- Apr 8, 2015
SanBio has no economic moat
SanBio Co Ltd lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Revenue & Expenses Breakdown
SanBio Co Ltd
Earnings Waterfall
SanBio Co Ltd
The intrinsic value for SanBio Co Ltd (SNBIF) under the Base Case is hidden USD.
Compared with the current market price of 16.45 USD, the stock appears hidden.